ICU Medical Inc
ICUI142.670USD
-1.960-1.36%
Close 12/31, 16:00（ET）Quotes delayed by 15 min
3.52BMarket Cap
LossP/E TTM
More Details of ICU Medical Inc Company
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
ICU Medical Inc Info
Ticker SymbolICUI
Company nameICU Medical Inc
IPO dateMar 31, 1992
CEOJain (Vivek)
Number of employees15000
Security typeOrdinary Share
Fiscal year-endMar 31
Address951 Calle Amanecer
CitySAN CLEMENTE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92673-6212
Phone19493662183
Websitehttps://www.icumed.com/
Ticker SymbolICUI
IPO dateMar 31, 1992
CEOJain (Vivek)
Company Executives of ICU Medical Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
155.21K
-29.08%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
30.35K
+21.62%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
11.30K
-20.41%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
8.46K
+16.53%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
6.09K
+154.83%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
4.75K
+56.92%
Ms. Laurie Hernandez
Ms. Laurie Hernandez
Independent Director
Independent Director
3.61K
+91.41%
Ms. Kolleen T. Kennedy
Ms. Kolleen T. Kennedy
Independent Director
Independent Director
3.29K
+110.31%
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
3.25K
--
Mr. Donald M. Abbey
Mr. Donald M. Abbey
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
155.21K
-29.08%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
30.35K
+21.62%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
11.30K
-20.41%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
8.46K
+16.53%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
6.09K
+154.83%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
4.75K
+56.92%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Infusion Consumables
273.13M
49.76%
Consumables
273.13M
49.76%
Infusion Systems
167.70M
30.55%
Vital Care
108.04M
19.68%
By RegionUSD
Name
Revenue
Proportion
United States
335.43M
61.11%
EMEA
99.06M
18.05%
APAC
58.40M
10.64%
Others
55.97M
10.20%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Infusion Consumables
273.13M
49.76%
Consumables
273.13M
49.76%
Infusion Systems
167.70M
30.55%
Vital Care
108.04M
19.68%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.04%
The Vanguard Group, Inc.
10.61%
Janus Henderson Investors
10.02%
Wasatch Global Investors Inc
10.01%
Fuller & Thaler Asset Management Inc.
5.61%
Other
50.72%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.04%
The Vanguard Group, Inc.
10.61%
Janus Henderson Investors
10.02%
Wasatch Global Investors Inc
10.01%
Fuller & Thaler Asset Management Inc.
5.61%
Other
50.72%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
56.82%
Investment Advisor
46.66%
Hedge Fund
8.58%
Research Firm
2.66%
Corporation
1.90%
Pension Fund
1.43%
Sovereign Wealth Fund
1.17%
Individual Investor
0.96%
Bank and Trust
0.64%
Institutional Shareholding
Updated: 2 hours ago
Updated: 2 hours ago
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
603
29.26M
118.52%
+2.55M
2025Q3
610
27.90M
113.00%
+1.26M
2025Q2
610
25.98M
105.53%
-2.00M
2025Q1
626
27.13M
110.25%
-2.28M
2024Q4
608
26.46M
107.92%
-3.56M
2024Q3
587
26.75M
109.35%
-2.77M
2024Q2
567
27.24M
111.60%
-1.50M
2024Q1
579
26.01M
106.82%
-1.69M
2023Q4
588
25.74M
106.69%
-1.14M
2023Q3
580
26.53M
109.94%
-1.49M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
3.22M
13.04%
-42.28K
-1.30%
Sep 30, 2025
The Vanguard Group, Inc.
2.62M
10.61%
-33.51K
-1.26%
Sep 30, 2025
Janus Henderson Investors
2.47M
10.02%
+3.39K
+0.14%
Sep 30, 2025
Wasatch Global Investors Inc
2.47M
10.01%
+2.47M
--
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.39M
5.61%
-4.81K
-0.35%
Sep 30, 2025
Millennium Management LLC
1.09M
4.41%
+690.69K
+173.40%
Sep 30, 2025
State Street Investment Management (US)
917.13K
3.72%
-10.67K
-1.15%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
872.99K
3.54%
+126.07K
+16.88%
Sep 30, 2025
Schroder Investment Management North America Inc.
796.70K
3.23%
+160.38K
+25.20%
Sep 30, 2025
Columbia Threadneedle Investments (US)
763.73K
3.09%
+187.22K
+32.48%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco S&P SmallCap Health Care ETF
1.82%
State Street SPDR S&P Health Care Equipment ETF
1.6%
JPMorgan Active Small Cap Value ETF
0.79%
Invesco S&P SmallCap 600 Pure Growth ETF
0.78%
JPMorgan Fundamental Data Science Small Core ETF
0.68%
Invesco NASDAQ Future Gen 200 ETF
0.51%
iShares S&P Small-Cap 600 Growth ETF
0.47%
State Street SPDR S&P 600 Small Cap Growth ETF
0.41%
OneAscent Enhanced Small and Mid Cap ETF
0.4%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.38%
View more
Invesco S&P SmallCap Health Care ETF
Proportion1.82%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.6%
JPMorgan Active Small Cap Value ETF
Proportion0.79%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion0.78%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.68%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.51%
iShares S&P Small-Cap 600 Growth ETF
Proportion0.47%
State Street SPDR S&P 600 Small Cap Growth ETF
Proportion0.41%
OneAscent Enhanced Small and Mid Cap ETF
Proportion0.4%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proportion0.38%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of ICU Medical Inc?
The top five shareholders of ICU Medical Inc are:
BlackRock Institutional Trust Company, N.A. holds 3.22M shares, accounting for 13.04% of the total shares.
The Vanguard Group, Inc. holds 2.62M shares, accounting for 10.61% of the total shares.
Janus Henderson Investors holds 2.47M shares, accounting for 10.02% of the total shares.
Wasatch Global Investors Inc holds 2.47M shares, accounting for 10.01% of the total shares.
Fuller & Thaler Asset Management Inc. holds 1.39M shares, accounting for 5.61% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 3.22M shares, accounting for 13.04% of the total shares.
The Vanguard Group, Inc. holds 2.62M shares, accounting for 10.61% of the total shares.
Janus Henderson Investors holds 2.47M shares, accounting for 10.02% of the total shares.
Wasatch Global Investors Inc holds 2.47M shares, accounting for 10.01% of the total shares.
Fuller & Thaler Asset Management Inc. holds 1.39M shares, accounting for 5.61% of the total shares.
What are the top three shareholder types of ICU Medical Inc?
The top three shareholder types of ICU Medical Inc are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Janus Henderson Investors
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Janus Henderson Investors
How many institutions hold shares of ICU Medical Inc (ICUI)?
As of 2025Q4, 603 institutions hold shares of ICU Medical Inc, with a combined market value of approximately 29.26M, accounting for 118.52% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 5.52%.
What is the biggest source of revenue for ICU Medical Inc?
In FY2025Q2, the Infusion Consumables business generated the highest revenue for ICU Medical Inc, amounting to 273.13M and accounting for 49.76% of total revenue.
